News
Public · Published
Nvidia's stock is on sale after Jensen Huang's exit. But is the selloff just beginning?
Nvidia shares have fallen more than 30% from their October 6 peak after CEO Jensen Huang resigned on Thursday, prompting concerns about governance, China ties and succession planning. Although demand remains high and an analyst projects 88% revenue growth to $406.9 billion this fiscal year, he downgraded the stock to market perform.
Published:
Updated:
What happened
Nvidia shares have fallen more than 30% from their October 6 peak after CEO Jensen Huang resigned on Thursday, prompting concerns about governance, China ties and succession planning. Although demand remains high and an analyst projects 88% revenue growth to $406.9 billion this fiscal year, he downgraded the stock to market perform.
Confirmed
Global impact / market context
The leadership change and governance questions could make investors less willing to pay for Nvidia shares, even while demand is strong. If uncertainty persists, a lower share price could raise the company's cost of attracting capital and make investors more cautious about AI-related spending.
Analyst inference
The article presents a sharp contrast: Nvidia's shares are down more than 30% from their peak, while an analyst still expects rapid revenue growth. The downgrade signals that anticipated growth may not offset worries about leadership continuity and future news.
Analyst inference
What to watch
- Watch for updates on the CEO transition and succession plan; the article says investors question whether a new leader can maintain Huang's direction and customer relationships. Analyst inference
- Track any further news about corporate governance or Nvidia's potential relationship with China, two issues the article identifies as contributing to scrutiny of the company. Analyst inference
- Compare future revenue results with the analyst's projection of $406.9 billion and 88% growth this fiscal year; a shortfall could intensify concerns about the share decline. Analyst inference
Evidence
- Original source link unavailable